Biodesix (BDSX) Short-term Investments (2021 - 2022)

Biodesix (BDSX) reported Short-term Investments of $100000.0 for Q2 2022, little changed quarter-over-quarter from $100000.0 in Q4 2021.

Biodesix (BDSX) Short-term Investments (2021 - 2022) Analysis & Trends

Biodesix has reported Short-term Investments for 2 years, with the latest figure at $100000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Short-term Investments changed N/A year-over-year to $100000.0; the trailing twelve-month figure through Jun 2022 stood at $100000.0 (changed N/A YoY), and the FY2021 full-year result was $100000.0, changed N/A from the prior year.
  • Short-term Investments for Q2 2022 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
  • The five-year high for Short-term Investments was $100000.0 in Q4 2021, with the low at $100000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 Biodesix 146.77 Mn 121.20 Mn 21.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2022 100,000.00
Dec 31, 2021 100,000.00